Have a personal or library account? Click to login
‘Lies, damned lies, and statistics’: pharmaceutical, device, and academic enterprises ‘in the dock’ Cover

‘Lies, damned lies, and statistics’: pharmaceutical, device, and academic enterprises ‘in the dock’

Open Access
|Feb 2017

References

  1. 1. Freedman DH. Lies, Damned Lies, and Medical Science. The Atlantic [Internet]. November 2010 [cited 2011 Jan 25]. Available from: http://www.theatlantic.com/magazine/archive/2010/11/lies-damned-lies-andmedical-science/8269/
  2. 2. Lehrer J. The Truth Wears Off. Is there something wrong with the scientific method? The New Yorker [Internet]. 2010 Dec 13 [cited 2011 Jan 25]; Available from: http://www.newyorker.com/reporting/2010/12/13/101213fa_fact_lehrer
  3. 3. Ioannidis JPA. Why most published research findings are false [Internet]. 2005 [cited 2011 Jan 25]; 2(8):124. Available from: http://www.plosmedicine.org10.1371/journal.pmed.0020124118232716060722
  4. 4. Ioannidis JPA. Contradicted and initially stronger effects in highly cited clinical research. JAMA. 2005; 294(2):218-28.10.1001/jama.294.2.21816014596
  5. 5. Editorial. Anticancer vitamins du Jour-The ABCED’s so far. Am J. Epidemiol. 2010; 172:1-3.10.1093/aje/kwq112289253520562190
  6. 6. Stolzenberg-Solomon RZ, Jacobs EJ, Arsian AA, Qi D, Patel AV, Helzisouer KJ, et al. Circulating 25- hydroxyvitamin D and risk of pancreatic cancer. Am J. Epidemiol. 2010; 172:81-93.
  7. 7. Campbell CC. Malaria Control-Addressing challenges to ambitious goals. NEJM. 2009; 361(5):522-3.10.1056/NEJMe090515919641210
  8. 8. World Health Organization. Global plan for artemisinin resistance containment [Internet]. 2011. [cited 2011 Jan 30]. Available from: http://www.who.int/malaria/publications/atozartemisinin_resistance_containment_2011.pdf)
  9. 9. Andersson DI, and Hughes D. Antibiotic resistance and its cost: is it possible to reverse resistance? [Internet] 2011. [cited 2011 Jan 29]. Available from: http://www.nature.com/nrmicro/journal/v8/n4/abs/nrmicro2319.html10.1038/nrmicro231920208551
  10. 10. Lundh A, Barbateskovic M, Hrobjartsson A, Gotzsche PC. Conflicts of interest at medical journals; the influence of industry-supported randomized trials on journal impact factors and revenues - cohort study [Internet]. 2010 [cited 2011 Jan 26]; 7 (10): e1000354. Available from: http://www.plosmedicine.org10.1371/journal.pmed.1000354296433621048986
  11. 11. Fleming TR. Addressing missing data in clinical trials. Ann Intern Med. 2011; 154:113-7.10.7326/0003-4819-154-2-201101180-00010331976121242367
  12. 12. Smyth RMD, Kirkham JJ, Jacoby A, Altman DG, Gamble C, Williamson PR. Frequency and reasons for outcome reporting bias in clinical trials: interviews with trialists. BMJ. 2010; 341:c7153.10.1136/bmj.c7153301681621212122
  13. 13. Chan AW. Bias, spin, and misreporting: time for full access to trial protocols and results [Internet]. 2008 [cited 2011 Jan 25]; 5 (11): 230. Available from: http://www.plosmedicine.org10.1371/journal.pmed.0050230258635919067481
  14. 14. Pfeiffer T, Rand DG, Dreber A. Decision-making in research tasks with sequential testing [Internet]. 2009 [cited 2011 Jan 25]; 4 (2): 4607. Available from: http://www.plosone.org10.1371/journal.pone.0004607264300819240797
  15. 15. Sinha IP, Smyth RL, Williamson PR. Using the Delphi technique to determine which outcomes to measure in clinical trials: recommendations for the future based on a systematic review of existing studies [Internet]. 2011 [cited 2011 Jan 26]. Available from: http://www.plosmedicine.org10.1371/journal.pmed.1000393302669121283604
  16. 16. Shrier I, Boivin JF, Platt RW, Steele RJ, Brophy JM, Carnevale F, et al. The interpretation of systematic reviews with meta-analyses: an objective or subjective process? [Internet]. BMC medical informatics and decision making. 2008 [cited 2011 Jan 28]; 8(19). Available from: http://www.biomedcentral.com/1472-6947-8-1910.1186/1472-6947-8-19240856718495019
  17. 17. Rising K, Bacchetti P, Bero L. Reporting bias in drug trials submitted to the Food and Drug Administration: review of publication and presentation [Internet]. 2008 [cited 2011 Jan 28]; 5 (11):e217. Available from: http://www.plosmedicine.org10.1371/journal.pmed.0050217258635019067477
  18. 18. Wikipedia the Free Encyclopedia. [Internet]. Randomized Controlled Trial. [updated 2011 Jan 25; cited 2011 Jan 31]. Available from: http://en.wikipedia.org/wiki/Randomized_controlled_trial
  19. 19. Pocock SJ, Travison TG, Wruck LM. Figures in clinical trial reports: current practice and scope for improvement [Internet]. 2011. [cited 2011 Jan 26]. Available from: www.trialsjournal.com/content/8/1/3610.1186/1745-6215-8-36222222118021449
  20. 20. Salanti G, Ades AE, Ioannidis JPA. Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial. J Clin Epidemiol. 2011; 64:163-71.10.1016/j.jclinepi.2010.03.01620688472
  21. 21. Glickman SW, McHutchison JG, Petersen ED, Cairns CB, Harrington RA, Califf RM, Schulman KA. Ethical and scientific implications of the globalization of clinical research. NEJM. 2009; 360(8):816-23.10.1056/NEJMsb080392919228627
  22. 22. Journal of Negative Results in Biomedicine. [cited 2011 Jan 28]. Available from: http://www.jnrbm.com
  23. 23. Godlee F, Smith J, Marcovitch H. Wakefield’s article linking MMR vaccine and autism was fraudulent. [cited 2011 Jan 15]. Available from: http://www.bmj.com/content/342/bmj.c7452.full.10.1136/bmj.c745221209060
  24. 24. Deer B. How the case against the MMR vaccine was fixed. [cited 2011 Jan 15]. Available from: http://www.bmj.com/content/342/bmj.c534710.1136/bmj.c534721209059
DOI: https://doi.org/10.5372/1905-7415.0502.022 | Journal eISSN: 1875-855X | Journal ISSN: 1905-7415
Language: English
Page range: 175 - 178
Published on: Feb 4, 2017
Published by: Chulalongkorn University
In partnership with: Paradigm Publishing Services
Publication frequency: 6 issues per year

© 2017 Robert E. Dedmon, published by Chulalongkorn University
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.